NasdaqCM:PLSEMedical Equipment
Assessing Pulse Biosciences (PLSE) Valuation After Recent Share Price Pullback And Ongoing Losses
Recent share performance and business profile
Pulse Biosciences (PLSE) has drawn attention after a strong share price move over the past 3 years, even as returns over the past month have been weaker and the stock remains volatile in the shorter term.
The company, valued at about US$1.42b, focuses on bioelectric medicine, with products built around its nPulse Nanosecond Pulsed Field Ablation platform. These systems target benign skin lesions and soft tissue ablation, including tools designed...